SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma
暂无分享,去创建一个
D. Reinke | K. Ballman | D. Hawkins | L. Helman | S. Strauss | B. Widemann | J. Whelan | Shreyaskumar R Patel | Yiping Zhang | J. Ji | R. Chugh | L. Mascarenhas | J. Glod | Yao Lu